Deep Tech Startups

NanoBioFab develops AI-powered nanosensor technology for rapid, non-invasive detection of pathogens through their gaseous signatures in clinical settings. The technology targets hospitals and enterprise healthcare systems for applications in orthopedics, wound care, urology, and pulmonology.

2 investors

Nanobots Therapeutics develops the MotionTx platform to create nanobots that penetrate tissues and enhance drug accumulation in target cells for therapeutic applications. The company is a spin-off of ICREA and IBEC resulting from research by Prof. Samuel Sánchez.

2 investors

NanoCarry is developing a proprietary drug-delivery technology platform designed to move therapeutic antibodies across the blood-brain barrier for the treatment of brain cancers and central nervous system diseases. The platform uses a "Plug & Play" approach aimed at substantially increasing the brain delivery of injected antibody doses.

2 investors

Nanocrine develops nanoplasmonic biosensor chips that let cell biology researchers image protein secretions from living cells in real time, without labels, using standard live-cell microscopes. Its single-use biochips apply surface plasmon resonance sensing to map extracellular secretions spatially, functioning like a real-time, microscope-based ELISA.

2 investors

Nanode Battery Technologies develops alloy-based anode materials for sodium-ion batteries, aiming to deliver high-energy-density, fast-charging cells through low-cost, eco-friendly manufacturing methods. The company positions its battery materials for use in customer projects requiring efficient and affordable energy storage.

2 investors

NanoFrontier develops and commercializes nanoparticle technologies derived from Tohoku University, enabling cost-effective solutions for water contamination detection, next-generation battery systems, cooling performance, hydrogen transport, and drug delivery applications. The company offers custom nanoparticle development, contract manufacturing, and technology licensing to industrial and research customers.

2 investors

Nanomox develops advanced materials and thin films, such as metal oxide particles ranging from nano to macro scale, using fine control of particle properties for a range of applications. The company positions its materials as more efficient than conventional ones for improving existing products and developing new ones.

2 investors

Nanopattern Technologies is a company focused on nanopatterning, with a team including chemists, researchers, and engineers working on materials and related technology.

2 investors

Nanophage Technologies develops biological nanorod scaffolds for diagnostic assay applications, enabling enhanced detection and sensitivity in clinical and research settings. The company serves diagnostics manufacturers, pharmaceutical discovery organizations, and clinical laboratories.

2 investors

Nano PharmaSolutions develops NanoTransformer, a patented nanodrug manufacturing platform that improves drug solubility and bioavailability, and delivery systems such as Nano-CNS for neurotherapeutics via nasal spray. The company applies its technology to drug-device combination products for the pharmaceutical industry.

2 investors

NanoPhoria is a life sciences company that raised an €83.5 million Series A round. The page focuses on its investors and does not detail its specific product or technology.

2 investors

Oxford Nanopore offers educational programs and tools to make DNA sequencing accessible to students and educators from high school through undergraduate levels. The company works with institutions and scientific educators to integrate nanopore sequencing technology into classroom settings and address the world's pressing challenges.

2 investors

nanoSkunkWorkX develops nanostructured Scalable Devices (nSDs) — embedded interface devices made from bulk graphene that control heat, charge, energy, and signal flow at system interfaces. The company focuses on turning raw graphene into manufacturable hardware through materials engineering.

2 investors

Nano-Tex develops textile treatment technologies applied to fabrics for properties such as water repellency, stain resistance, moisture wicking, wrinkle resistance, and UV protection. It offers branded finishes (e.g. Aquapel, Dry Inside, Wick+Block) and related product materials like hangtags for apparel and textile manufacturers.

2 investors

NanoVation Therapeutics develops lipid nanoparticle (LNP) and mRNA delivery technologies for gene therapies, supporting drug development partners across mRNA synthesis, LNP formulation, and preclinical delivery optimization. It works with pharmaceutical and biotech partners on end-to-end gene therapy delivery.

2 investors

Nanovery develops DNA-based nanorobotic sensors that quantify nucleic acid sequences, such as RNA therapeutics and biomarkers, in liquid samples using a standard plate reader. The platform serves biotechnology research and therapeutic analysis workflows.

2 investors

NIF is a venture capital fund focused on defence and innovation, working with government stakeholders, limited partners, and startups. It operates offices in Amsterdam and London.

2 investors

Nature Architects develops computational design technologies that create new possibilities across industries, products, and technical domains by leveraging advanced design methodologies.

2 investors

Nayam Innovations is an IP-driven medical device startup developing a customization technology platform for intraocular lenses (IOLs) that lets surgeons and patients personalize lenses for spectacle-free vision after cataract surgery. It aims to make hydrophobic foldable IOLs affordable to cataract patients, serving the ophthalmic surgery market in India.

2 investors

Ncardia develops induced pluripotent stem cell (iPSC) technologies and services for drug discovery, safety testing, and regenerative medicine applications. The company serves pharmaceutical and biotech organizations seeking advanced cellular models to accelerate therapeutic development and validate drug candidates.

2 investors

NDT Global manufactures advanced ultrasonic inspection systems for detecting and analyzing defects in assets, providing operators with data-driven risk management and asset integrity predictions.

2 investors

Nebuflow develops drug delivery technology for pharmaceutical applications. The company focuses on transforming how life-changing drugs are delivered.

2 investors

Nectin Therapeutics develops novel monoclonal antibodies and antibody-drug-conjugates to treat difficult-to-treat cancers by targeting immune evasion mechanisms. The company is a biotech firm with a pipeline focused on oncology immunotherapy, including its lead candidate NTX1088 currently in clinical trials.

2 investors

Neo is a blockchain platform that enables smart contracts and decentralized applications, originally founded as Antshares and rebranded in 2017 to reflect its Smart Contracts 2.0 implementation. The platform has undergone upgrades to version N3, offering features like distributed storage, oracles, and name services for blockchain developers.

2 investors